Related Experiment Video
Updated: Dec 7, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial Myopathy Underlying Atrial Fibrillation
Harold Rivner1, Raul D Mitrani1, Jeffrey J Goldberger1
1Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, US.
Atrial myopathy, a key factor in atrial fibrillation (AF), is often overlooked in current treatments. Targeting this underlying condition, particularly atrial fibrosis, shows promise in reducing AF occurrence and burden.
Area of Science:
- Cardiology
- Electrophysiology
- Biomedical Engineering
Background:
- Atrial fibrillation (AF) commonly arises from underlying atrial disease.
- Current AF assessment and treatment strategies do not adequately address the contributing atrial myopathy.
- Atrial myopathy, including fibrosis, can create a cycle where it leads to AF, which then exacerbates the myopathy.
Purpose of the Study:
- To highlight the significance of atrial myopathy as a substrate for AF.
- To emphasize the need for therapies that target the underlying atrial myopathy.
- To review current methods for assessing atrial myopathy and discuss emerging therapeutic approaches.
Main Methods:
- Review of existing literature on atrial myopathy and AF.
- Discussion of diagnostic techniques: ECG, plasma biomarkers, electroanatomical voltage mapping, echocardiography, and cardiac MRI.
- Analysis of current AF treatments and their limitations regarding atrial myopathy.
Main Results:
- Atrial myopathy, especially fibrosis, is a critical substrate for AF.
- Existing diagnostic tools can identify and quantify aspects of atrial myopathy.
- Current AF treatments like catheter ablation do not directly resolve the underlying myopathy.
Conclusions:
- Addressing atrial myopathy is crucial for effective AF management.
- Emerging research suggests that targeting atrial myopathy can decrease AF incidence and burden.
- A shift towards treating the substrate of AF, rather than just the arrhythmia, is needed.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Cardiomyopathy V: Interprofessional Care
Mechanism of Cardiac Arrhythmias

